top of page

Mwandishi:

Mhariri:

Imeboreshwa;

ULY CLINIC

ULY CLINIC

27 Oktoba 2026, 13:25:33

Image-empty-state.png

Sickle cell disease: acute chest syndrome (detailed national guideline)

Sickle cell disease: acute chest syndrome (detailed national guideline)

Chanzo: National Sickle Cell Disease Management Guidelines, Ministry of Health Tanzania. Toleo: 2nd edition, June 2026. Mwongozo wa Taifa (supporting guideline). The STG 2026 article "Acute chest syndrome in sickle cell disease" remains the main reference.

When to treat as acute chest syndrome

Treat as a chest crisis if the patient has signs of respiratory distress (fast breathing, chest wall recession, nasal flaring, grunting, and hypoxia with SpO2 <95% on air) and/or any of the following:

  • Pain, often pleuritic (worse with breathing), in the chest wall, abdomen or back.

  • Cough.

  • Wheeze.

  • High fever, tachycardia.

  • Infiltrates on chest X-ray.

Investigations

  • Arterial blood gases, creatinine, electrolytes, ALT.

  • Full blood count, malaria test, blood and urine culture and sensitivity, CRP.

  • Chest X-ray. Physical signs often appear before chest X-ray changes.

  • HPLC to establish the baseline haemoglobin S percentage, in case exchange transfusion is needed.

Management

  • Pain relief according to the pain protocol (companion article "Sickle cell disease: pain relief and morphine management"). Take care not to over-sedate with opioids.

  • Place an IV cannula and collect blood for investigations.

  • Oxygen: give supplemental oxygen to keep the oxygen saturation above 95%.

  • Fluids: hydrate according to the hydration protocol, but avoid fluid overload and reassess regularly (in ACS start with half of the usual volumes; see "Sickle cell disease: emergency assessment and first treatment").

  • Antibiotics: IV ceftriaxone 70–100 mg/kg once daily OR amoxicillin-clavulanic acid 30 mg/kg/dose 8-hourly, for 10 days.

  • Macrolide: add azithromycin or clarithromycin to cover atypical microorganisms.

  • Top-up blood transfusion: give 10 mL/kg packed red blood cells to patients with symptomatic ACS whose haemoglobin is more than 1.0 g/dL below their baseline. If the baseline haemoglobin is 9 g/dL or higher, a top-up transfusion may not be needed.

  • Exchange blood transfusion: do an urgent exchange transfusion when ACS progresses rapidly, shown by oxygen saturation below 90% despite supplemental oxygen, increasing respiratory distress, progressive pulmonary infiltrates, and/or a fall in haemoglobin despite simple transfusion. (Exchange transfusion is described in "Sickle cell disease: blood transfusion - simple, top-up and exchange".)

  • Maximum time from the decision to transfuse to the start of the transfusion: 12 hours.

  • Incentive spirometry (for example, blowing up a balloon).

  • Mobilise the patient as soon as possible.

  • Inform the anaesthetist/intensivist early; mechanical ventilation may be needed later.

  • Continuous hourly monitoring: pulse, respiratory rate and oxygen saturation by pulse oximetry.

Acute chest syndrome is life-threatening: admit to a high dependency unit or intensive care unit (ICU).

⚠ Tofauti na STG 2026: STG 2026 lists the same criteria, investigations, oxygen target, antibiotics and transfusion. The national guideline adds a macrolide for atypical organisms, the haemoglobin threshold for top-up transfusion (more than 1.0 g/dL below baseline; may not be needed if baseline Hb is 9 g/dL or higher), criteria for urgent exchange transfusion, the 12-hour decision-to-transfusion limit and incentive spirometry. Analgesic doses differ: see "Sickle cell disease: pain relief and morphine management".

Imeandikwa:

27 Oktoba 2026, 13:23:58

Rejea za mada:

1. Ministry of Health Tanzania. National Sickle Cell Disease Management Guidelines, 2nd edition. June 2026. Part II, section 3: Acute chest syndrome (pages 13–14).
2. Ministry of Health Tanzania. STG-NEMLIT 7th edition, 2026: Acute chest syndrome in sickle cell disease.

bottom of page